Top

Journal of Radiation Oncology

Published in:

01-09-2019 | Brachytherapy | Letter to the Editor

Letter to the Editor concerning “Re-irradiation in gynaecological cancers, present experiences and future hopes”

Authors: Amelia Barcellini, Viviana Vitolo, Edoardo Mastella, Alfredo Mirandola, Francesca Valvo

Published in: Journal of Radiation Oncology | Issue 3/2019

Excerpt

To the Editor, …

Banerjee S, Goyal S, Kataria T et al (2018) Re-irradiation in gynaecological cancers, present experiences and future hopes. J Radiat Oncol 7:205CrossRef

Dornhöfer Nand Höckel M (2008) New developments in the surgical therapy of cervical carcinoma. Ann N Y Acad Sci 1138:233–252CrossRef

Gadducci A, Tana R, Cosio S, Cionini L (2010) Treatment options in recurrent cervical cancer (Review). Oncol Lett 1(1):3–11CrossRef

Gadducci A, Guerrieri ME, Cosio S, Fabrini MG, Laliscia C, Attianese D, Rossi A, Ferrero A (2018) Rates, Sites and times of recurrence and clinical outcome of endometrial cancer patients with histologically-positive nodes: an Italian two-center retrospective study. Anticancer Res 38(3):1695–1703PubMed

Panek G, Gawrychowski K, Sobiczewski P, Derlatka P, Danska-Bidzinska A, Gmyrek Land Bidzinski M (2007) Results of chemotherapy for pulmonary metastases of carcinoma of the cervix in patients after primary surgical and radiotherapeutic management. Int J Gynecol Cancer 17:1056–1061CrossRef

Zola P, Fuso L, Mazzola S, Piovano E, Perotto S, Gadducci A, Galletto L, Landoni F, Maggino T, Raspagliesi F, Sartori Eand Scambia G (2007) Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecol Oncol 107(Suppl 1):150–154CrossRef

Gadducci A, Cosio S, Fabrini MG, Fanucchi A, Barsotti C, Cristofani R, Greco C, Genazzani AR (2011) Patterns of failures in endometrial cancer: clinicopathological variables predictive of the risk of local, distant and retroperitoneal failure. Anticancer Res 31(10):3483–3488PubMed

Laliscia C, Cosio S, Morganti R, Mazzotti V, Fabrini MG, Paiar F, Gadducci A (2019) Patterns of failures and clinical outcome of patients with early-stage, high-risk, node-negative endometrial cancer treated with surgery followed by adjuvant platinum-based chemotherapy and vaginal brachytherapy. Oncology. 96(5):235–241CrossRef

Laliscia C, Gadducci A, Fabrini MG, Barcellini A, Parietti E, Pasqualetti F, Morganti R, Mazzotti V, Cafaro I, Paiar F (2019 Feb) Definitive radiotherapy for recurrent vulvar carcinoma after primary surgery: a two-institutional Italian experience. Tumori. 21:300891618811279

10.

Verma V, Simone CB 2nd, Wahl AO, Beriwal S, Mehta MP (2016) Proton radiotherapy for gynecologic neoplasms. Acta Oncol 55(11):1257–1265CrossRef

11.

Hall EJ, Giacca AJ (2012) Radiobiology for the radiologist. Lippincott Williams & Wikins, Philadelphia

12.

Tsujii H, Kamada T, Shirai T, Noda K, Tsuji H, Karasawa K (2013) In: Tsujii H, Kamada T, Shirai T, Noda K, Tsuji H, Karasawa K (eds) Carbon-ion radiotherapy. Springer Science & Business Media, Tokyo, pp 127–309

13.

Durante M, Loeffler JS (2010) Charged particles in radiation oncology. Nat Rev Clin Oncol 7:37–43CrossRef

14.

Cai G, Zhu J, Palmer JD, Xu Y, Hu W, Gu W, Cai S, Zhang Z (2015) CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer. Radiat Oncol 10:57CrossRef

15.

Shiba S, Okonogi N, Kato S, Wakatsuki M, Kobayashi D, Kiyohara H, Ohno T, Karasawa K, Nakano T, Kamada T (2017) Clinical impact of re-irradiation with carbon-ion radiotherapy for lymph node recurrence of gynecological cancers. Anticancer Res 37(10):5577–5583PubMed

16.

Barcellini A, Vitolo V, Lazzari R, Fiore MR et al (2018) EP-1497 Particle radiotherapy for re-irradiation of pelvic recurrences of gynecological cancer. Radiother Oncol 133(Supplement 1):S810–S811

Title: Letter to the Editor concerning “Re-irradiation in gynaecological cancers, present experiences and future hopes”
Authors: Amelia Barcellini
Viviana Vitolo
Edoardo Mastella
Alfredo Mirandola
Francesca Valvo
Publication date: 01-09-2019
Publisher: Springer Berlin Heidelberg
Keywords: Brachytherapy
Gynecologic Cancer
Radiotherapy
Published in: Journal of Radiation Oncology / Issue 3/2019
Print ISSN: 1948-7894
Electronic ISSN: 1948-7908
DOI: https://doi.org/10.1007/s13566-019-00396-w

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2019

Patterns of utilization and comparative efficacy of altered fractionation and concurrent chemoradiation for treatment for T2N0M0 glottic carcinoma

Assessment of the alpha/beta ratio of the optic pathway to adjust hypofractionated stereotactic radiosurgery regimens for perioptic lesions

Evaluating improvements in cardiac dosimetry in breast radiotherapy and comparison of cardiac sparing techniques

Challenges in the re-irradiation of locally advanced head and neck cancers: outcomes and toxicities

Dosimetric evaluation of the dose calculation accuracy of different algorithms for two different treatment techniques during whole breast irradiation

Definitive chemoradiation followed by stereotactic body radiotherapy boost for inoperable endometrial cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer